华强科技: 华泰联合证券有限责任公司关于湖北华强科技股份有限公司首次公开发行股票并在科创板上市之保荐总结报告书

Group 1 - The core viewpoint of the report is to summarize the sponsorship and regulatory compliance of Hubei Huqiang Technology Co., Ltd. during its initial public offering (IPO) on the Sci-Tech Innovation Board [1] - The issuer, Hubei Huqiang Technology Co., Ltd., has a registered capital of 344.5 million yuan and was listed on December 6, 2021 [1] - The report outlines the responsibilities of the sponsor, Huatai United Securities, including due diligence, document preparation, and compliance with regulatory requirements [1][3] Group 2 - The net amount raised from the IPO was 2.8121508 billion yuan, allocated to various projects including the "New Nuclear Biochemical Emergency Rescue Protection Equipment Industrialization Production Base Project" [4] - As of 2024, the balance of the special account for raised funds was 1.69612742 billion yuan, which includes idle funds used for cash management [4] - The sponsor has issued independent opinions on the use of raised funds for the years 2021, 2022, and 2023, confirming compliance with relevant regulations and no violations in fund usage [6][7][13] Group 3 - The report details the continuous supervision activities conducted by the sponsor, including on-site inspections and reviews of the issuer's governance and fund usage [3][4] - The sponsor has issued 24 verification opinions during the supervision period, with no disapprovals noted [8] - The issuer has been responsive to regulatory inquiries and has made necessary corrections regarding financial reporting and fund management [10][11]